AI assistant
Sending…
Lexaria Bioscience Corp. — Director's Dealing 2019
Aug 6, 2019
34983_dirs_2019-08-06_dde9f34c-32c4-4de9-9f2c-4e8d6f436fa2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Lexaria Bioscience Corp. (LXRP)
CIK: 0001348362
Period of Report: 2019-05-06
Reporting Person: McKechnie William Edward (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-05-06 | Stock Options | $0.99 | A | 150000 | Acquired | 2024-05-06 | Common Shares (150000) | Direct |
More from Lexaria Bioscience Corp.
Interim / Quarterly Report
2026
Apr 13
Director's Dealing
2026
Mar 18
Delisting Announcement
2026
Feb 6
Regulatory Filings
2026
Jan 28
Declaration of Voting Results & Voting Rights Announcements
2026
Jan 28
Capital/Financing Update
2026
Jan 14
Delisting Announcement
2026
Jan 14
Interim / Quarterly Report
2026
Jan 13
Capital/Financing Update
2025
Dec 29
Regulatory Filings
2025
Dec 19